Difference between revisions of "Comment Resolutions"

From QIBA Wiki
Jump to: navigation, search
(Sorted by date of feedback closure)
Line 12: Line 12:
 
| colspan="4" align="center" style="background:#dddddd" | '''CT Profiles'''
 
| colspan="4" align="center" style="background:#dddddd" | '''CT Profiles'''
 
|-
 
|-
| [[Media:QIBA_CTA_Profile_as_of_2019-Feb-29.pdf| CT Atherosclerosis 2019-02-29]]
+
| [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx| CT Small Lung Nodule Screening 2016-06-01]]
 
| Public Comment
 
| Public Comment
| 2019.06.03
+
| 2016.09
| [[Media:QIBA_CTA_Comments_all resolved.xlsx| Public Comment Resolutions 2020-03-12]]
+
| [[Media:2018-06-15 v9 QIBA SLN CommentsAndResolutions.xlsx|Public Comment Resolutions 2018-06-15]]  
 
|-
 
|-
 
| [[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21b]]  
 
| [[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21b]]  
Line 21: Line 21:
 
| 2017.02
 
| 2017.02
 
| [https://docs.google.com/spreadsheets/d/1cyz0frvELb6Tq1EHjpHxnvjeUxotExnJ3OrKPdIa30U/edit?usp=sharing Technical Confirmation Resolutions 2018-02-25]
 
| [https://docs.google.com/spreadsheets/d/1cyz0frvELb6Tq1EHjpHxnvjeUxotExnJ3OrKPdIa30U/edit?usp=sharing Technical Confirmation Resolutions 2018-02-25]
 +
|-
 +
| [[Media:QIBA_CTA_Profile_as_of_2019-Feb-29.pdf| CT Atherosclerosis 2019-02-29]]
 +
| Public Comment
 +
| 2019.06.03
 +
| [[Media:QIBA_CTA_Comments_all resolved.xlsx| Public Comment Resolutions 2020-03-12]]
 
|-
 
|-
 
| [[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-3.pdf|CT Small Lung Nodule Screening 2018-11-18]]
 
| [[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-3.pdf|CT Small Lung Nodule Screening 2018-11-18]]
Line 26: Line 31:
 
| 2020.04
 
| 2020.04
 
| '''Resolving Feedback'''
 
| '''Resolving Feedback'''
|-
 
| [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx| CT Small Lung Nodule Screening 2016-06-01]]
 
| Public Comment
 
| 2016.09
 
| [[Media:2018-06-15 v9 QIBA SLN CommentsAndResolutions.xlsx|Public Comment Resolutions 2018-06-15]]
 
 
|-
 
|-
 
| colspan="4" align="center" style="background:#dddddd" | '''MR Profiles'''
 
| colspan="4" align="center" style="background:#dddddd" | '''MR Profiles'''
 
|-
 
|-
| [[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf| MR DWI 2019-02-05]]
+
| [[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| MR DWI 2017-04-27]]
| Public Comment #2
+
| 2019.04.05
+
| [[Media:QIBA DWI Profile-Public Comment--2 Resolutions.pdf| Public Comment Resolutions]]
+
|-
+
| [[Media:QIBA_fMRI_Profile_1_PC-rev1.pdf| fMRI Sensorimotor 2017-06-19]]
+
 
| Public Comment
 
| Public Comment
| 2017.12.31
+
| 2017.08.25
 
| '''Resolving Feedback'''
 
| '''Resolving Feedback'''
 
|-
 
|-
Line 49: Line 44:
 
| '''Resolving Feedback'''
 
| '''Resolving Feedback'''
 
|-
 
|-
| [[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| MR DWI 2017-04-27]]
+
| [[Media:QIBA_fMRI_Profile_1_PC-rev1.pdf| fMRI Sensorimotor 2017-06-19]]
 
| Public Comment
 
| Public Comment
| 2017.08.25
+
| 2017.12.31
 
| '''Resolving Feedback'''
 
| '''Resolving Feedback'''
 +
|-
 +
| [[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf| MR DWI 2019-02-05]]
 +
| Public Comment #2
 +
| 2019.04.05
 +
| [[Media:QIBA DWI Profile-Public Comment--2 Resolutions.pdf| Public Comment Resolutions]]
 
|-
 
|-
 
| colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles'''
 
| colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles'''
 +
|-
 +
| SPECT Ioflupane in Neurodegenerative Disease v1.1
 +
| Public Comment
 +
| 2016.12.31
 +
| [[Media: SPECT Profile Response to Public Comments.v2017 06 06.xlsx | Public Comment Resolutions 2017-06-06]]
 
|-
 
|-
 
| [[Media:QIBA_AmyloidPET_15June2017.pdf| PET Amyloid 2019-06-15]]
 
| [[Media:QIBA_AmyloidPET_15June2017.pdf| PET Amyloid 2019-06-15]]
Line 65: Line 70:
 
| n/a
 
| n/a
 
| v2.0 is an update of v1.0 without additional public comment
 
| v2.0 is an update of v1.0 without additional public comment
|-
 
| SPECT Ioflupane in Neurodegenerative Disease v1.1
 
| Public Comment
 
| 2016.12.31
 
| [[Media: SPECT Profile Response to Public Comments.v2017 06 06.xlsx | Public Comment Resolutions 2017-06-06]]
 
 
|-
 
|-
 
| [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| SPECT 99mTC 2020-05-12]]
 
| [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| SPECT 99mTC 2020-05-12]]

Revision as of 23:44, 7 July 2020

Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.

Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.


Profile Document Feedback Type Feedback Closed Resolutions
CT Profiles
CT Small Lung Nodule Screening 2016-06-01 Public Comment 2016.09 Public Comment Resolutions 2018-06-15
CT Tumor Volumetry for Advanced Disease 2016-11-21b Technical Confirmation 2017.02 Technical Confirmation Resolutions 2018-02-25
CT Atherosclerosis 2019-02-29 Public Comment 2019.06.03 Public Comment Resolutions 2020-03-12
CT Small Lung Nodule Screening 2018-11-18 Technical Confirmation 2020.04 Resolving Feedback
MR Profiles
MR DWI 2017-04-27 Public Comment 2017.08.25 Resolving Feedback
MR Elastography 2017-08-15 Public Comment 2017.09.15 Resolving Feedback
fMRI Sensorimotor 2017-06-19 Public Comment 2017.12.31 Resolving Feedback
MR DWI 2019-02-05 Public Comment #2 2019.04.05 Public Comment Resolutions
PET/NM Profiles
SPECT Ioflupane in Neurodegenerative Disease v1.1 Public Comment 2016.12.31 Public Comment Resolutions 2017-06-06
PET Amyloid 2019-06-15 Public Comment 2017.09.15 Public Comment Resolutions 2018-05-02
SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15 Public Comment n/a v2.0 is an update of v1.0 without additional public comment
SPECT 99mTC 2020-05-12 Public Comment 2020.02.03 Public Comment Resolutions 2020-05-12